News & Articles

The disease has re-emerged in major wheat growing areas and an epidemic could cause a major threat to global food security

Discover the impact of base editing technology and learn how to introduce it into your cell therapy pipeline

Watch this on-demand webinar to learn more about manipulating the genes within physiologically relevant human immune cells

Learn how the latest proteomics technology is driving large-scale, high-throughput studies in disease biology

Trends in biomarker discovery methods and novel techniques advancing research, clinical diagnostics and therapeutic development

Watch this on-demand webinar to discover how gel-encapsulated microdroplets can be analyzed by high-throughput droplet sorting for genomic, proteomic, and metabolomic profiling

Sangmi Han discusses how cell counters have become an integral part of Macrogen’s single-cell RNA sequencing workflow

Addition of CRISPR and RNAi offerings to complement PerkinElmer's life sciences and applied genomics solutions, with future opportunities to improve cell based discovery for precision medicine

From Alzheimer’s disease to 3D brain modeling: Watch top speakers and connect with leading neuroscience innovators online, November 17-18

Join us Monday, November 16, to explore the advantages and applications of direct molecular testing

Which new products made the most difference to your lab work this year?

The study leverages the Tapestri Platform to illustrate the single-cell atlas of acute myeloid leukemia (AML) with multi-omics, describing the clonality underlying therapeutic resistance

Proven, scalable platform aims to increase dose yields and reduces process development time for cell and gene therapies

The collaboration will focus on the investigation of clinically relevant molecular targets for use in the development of advanced diagnostic testing for epilepsy

Watch world-renowned experts and connect with leading innovators on the hottest topics, new developments and latest technologies in neuroscience

Join us Thursday, November 5, to learn how to introduce base editing technology into your cell therapy pipeline

The Phase II clinical trial, which will use cutting-edge CRISPR genetic engineering, has already begun enrolling patients

Join us Tuesday, October 13, to hear from the multiplexing experts behind our four-part digital pathology webinar series

The Royal Swedish Academy of Sciences awards Nobel Prize in Chemistry 2020 to Emmanuelle Charpentier and Jennifer A. Doudna for the development of a method for genome editing

Explore our roundup of key considerations for a successful CRISPR/Cas9 experiment